The Biostatistics and Bioinformatics Core for the University of Texas M. D. Anderson Cancer Center (UTMDACC) Melanoma SPORE will serve multiple needs for the planning and conduct of the SPORE's translational reseal-ch. Based on a strong track record for providing biostatistical support for translational research, the Core will be,a comprehensive, muiti^lateral respurce for designing clinical and basic science experiments, performing statistical analyses, developing innovative statistical methodology, and publishing the research results generated from this Melanoma SPORE. For this proposed competitive renewal, we plan to continue and to expand the role of the Core in supporting the UTMDACC Melanoma SPORE. We will incorporate sound experimental design principles within each project that will increase the clarity,and enhance interpretability of study results. Each project will be provided with tailored analyses, accompanied by novel statistical development as necessary;to reveal apparent and hidden relationships among data.. The Core will collaborate with all project investigators to facilitate the timely publication of Melanoma SPORE research. The main objectives of the Biostatistics and Bioinformatics Core are: 1. To provide guidance for the statistical design and sample size and power calculations for each project. 2. To provide all statistical data analysis including descriptive statistical analysis, hypothesis testing, estimation, and modeling bf prospectively generated data., 3. To ascertain that conclusions drawn, from a|l projects are based on well-designed experiments and appropriate interpretation of results. 4. To develop and adapt innovative statistical methods pertinent to translational melanoma studies. 5. To generate statistical reports for all projects. 6. To collaborate and assist all project investigators in the publication of scientific results.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas MD Anderson Cancer Center
United States
Zip Code
(2018) Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet 50:668-681
Shah, Maitri Y; Ferracin, Manuela; Pileczki, Valentina et al. (2018) Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res 28:432-447
Huckins, L M; Hatzikotoulas, K; Southam, L et al. (2018) Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa. Mol Psychiatry 23:1169-1180
Kim, Sun-Hee; Roszik, Jason; Cho, Sung-Nam et al. (2018) The COX2 effector microsomal PGE2 synthase-1 is a regulator of immunosuppression in cutaneous melanoma. Clin Cancer Res :
Zhang, Tongwu; Choi, Jiyeon; Kovacs, Michael A et al. (2018) Cell-type-specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes. Genome Res 28:1621-1635
Velazquez-Torres, Guermarie; Shoshan, Einav; Ivan, Cristina et al. (2018) A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression. Nat Commun 9:461
Cascone, Tina; McKenzie, Jodi A; Mbofung, Rina M et al. (2018) Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy. Cell Metab 27:977-987.e4
Li, Bo; Wang, Yanru; Xu, Yinghui et al. (2018) Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer 142:2303-2312
Teerlink, Craig C; Huff, Chad; Stevens, Jeff et al. (2018) A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma. J Natl Cancer Inst :
Bezrookove, Vladimir; Nosrati, Mehdi; Miller 3rd, James R et al. (2018) Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma. Clin Cancer Res 24:4119-4125

Showing the most recent 10 out of 290 publications